Author | Lecia V. Sequist, MD | OncLive

Author | Lecia V. Sequist, MD

Articles

Dr. Sequist Discusses Combination Regimens in EGFR+ NSCLC

February 14, 2018

Video

Lecia V. Sequist, MD, associate professor of medicine, Harvard Medical School, Mary B. Saltonstall Chair, Oncology, Massachusetts General Hospital Center, discusses combination regimens for patients with EGFR-positive non-small cell lung cancer (NCSLC).

Dr. Sequist Distinguishes Osimertinib From Earlier NSCLC TKIs

February 01, 2018

Video

Lecia V. Sequist, MD, associate professor of medicine, Harvard Medical School, Mary B. Saltonstall Chair, Oncology, Massachusetts General Hospital Center, discusses the tolerability of a new third-generation T790-specific inhibitor, osimertinib (Tagrisso).

Dr. Sequist Discusses the OS Analysis of LUX-Lung 3 and LUX-Lung 6

October 30, 2014

Video

Lecia V. Sequist, MD, medical oncologist, associate professor, Massachusetts General Hospital, Harvard Medical School, discusses the overall survival analysis of the LUX-Lung 3 and LUX-Lung 6 trials.

Dr. Sequist Discusses the Efficacy of CO-1686 for NSCLC

June 23, 2014

Video

Lecia V. Sequist, MD, medical oncologist, associate professor, Massachusetts General Hospital, Harvard Medical School, discusses the efficacy of CO-1686 for the treatment of non-small cell lung cancer.

x